We are live on
!
Find out more
CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
13 hedge funds and large institutions have $1.4M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$304K | |
| 2 | +$144K | |
| 3 | +$15.7K | |
| 4 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$4.44K |
Top Sellers
| 1 | -$411K | |
| 2 | -$271K | |
| 3 | -$191K | |
| 4 |
PFS
Prospera Financial Services
Dallas,
Texas
|
-$166K |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$28.5K |